Genetic deletion of Par-4 using shRNA, CRISPR or siRNA inhibited LC3-II conversion and p62/SQSTM1 degradation in glioma cells induced by RSL3 and ML210, and erastin (Fig. 3k–m and Supplementary Fig. 3i, j). This evidence concerns the gene PAWR and central nervous system cancer.